Our experts - Carlos Aguiar, Elena Arbelo, Davide Capodanno, Victoria Delgado, Isabel Goncalves, Stefan James, Carol Ann Remme and Giuseppe Rosano – bring you the highlights from trials released during ACC.22 and their impact on clinical practice.
Carlos Aguiar give his insights on DIAMOND (Patiromer For The Management Of Hyperkalemia In Subjects Receiving Renin-angiotensin-aldosterone System Inhibitor Medications For HFrEF) trial.
[ Ссылка ]
The video content has been made available for informational and educational purposes only and is aimed at a professional audience. It only represents the views and opinions of the original creators of such content.
The information contained in the video has not been approved by the French National Agency for the Safety of Medicines and Health Products (ANSM). Always seek the advice of your physician or another qualified health care provider with any questions you may have regarding a medical condition.
[ Ссылка ]
![](https://i.ytimg.com/vi/rDbAqRdunKg/mqdefault.jpg)